中文版 | English
Company Profile
Your Location:Home > About Us > Company Profile

Welcome to Shenzhen Neptunus Interlong Bio-technique Co.Ltd.


Mission: to safeguard human's health. 

Position: to commit to life's responsibility.


a GMP certified biological pharmaceutical manufacturer in China 

a new vaccine manufacturer with best premises, facilities and equipments in China.

a leading biological products exporter in China.

 

Profile

Shenzhen Neptunus Interlong Bio-Technique Co. LTD, a hi-tech enterprise, covers research and development, production, sales and distribution under the guidance of the mission"Safeguard human's health", and specializes in gene engineering drugs and preventive biological products. Its main products are recombinant human interferon a-2b for injection (rhIFN a-2b), recombinant human interleukin-2 for injection (rhIL-2) and subunit influenza vaccine. Due to many years of excellent management, it keeps its leading status in domestic market and pursues the strategy of internationalization.

 

Research and development

Shenzhen Neptunus Interlong Bio-Technique Co. LTD has a leading level of research and development and possesses its own excellent team for research and development. Its laboratories are all equipped with advanced facilities and, in particular, its pilot laboratory reaches GMP standard and is approved as the center for vaccine engineering of Shenzhen. It also cooperates with many institutes and has achieved a number of achievements. 

Now it is developing a variety of cytokines products and vaccines due to their advantages of low cost, high efficiency, safety and reliability. In addition, it owns several patents for the core techniques and continues to apply for more patents. In near future, it will put a few new products with bright potential into the market.

 

Quality Control 

Quality control is of the same importance as research and development, and therefore Shenzhen Neptunus Interlong Bio-Technique Co. LTD has taken strict and comprehensive measures for the sake of quality control and as a result, high reputation is achieved in China. It complies with GMP standard all the time. For example, the production of rhIFN α-2b for injection, one of its products, has reached GMP standard and accordingly rhIFN α-2b for injection is approved by a few countries, including Indonesia and Pakistan, further enhancing its recognition of quality control.

 

Management 

Shenzhen Neptunus Interlong Bio-Technique Co. LTD understands thoroughly the pharmaceutical industry and has a sharp eye on its direction and strategy. In addition, it possesses more than 20 years of experience of management, and meanwhile puts an emphasis on staff training and actively recruits talents for sustaining development of human resources.

 

Market potential 

In the past, medication expenditure and vaccination rate in China lagged far behind developed countries. Nevertheless, Chinese economic boom has improved people's livelihood, and thus a higher awareness of healthcare, along with the population aging, has increased rapidly the demand for medication. Furthermore, the standard of biological products in China is progressed close to the international one, indicative of a beneficial and promising outlook for future development. 

Therefore, the business of Shenzhen Neptunus Interlong Bio-Technique Co. LTD is bound to grow and unleash boundless opportunities to its partners.

 

Brand 

All products of Shenzhen Neptunus Interlong Bio-Technique Co. LTD are marketed under the trademark either"Neptunus"or"Interlong", both of which have been top brands in China for quite a few years. High reputation and recognition in the field are achieved. Thereof "Interlong" is its proprietary brand. To a large extent, these two top brands guarantee market acceptance of new products and ensure high competition in the market. 

 

Distribution

Shenzhen Neptunus Interlong Bio-Technique Co. LTD adopts all kinds of distribution modes, such as bidding and agency, to avoid the risk of sales. Its products have covered more than 20 provinces in China, and been serving around 500 medical organizations around China. Such an extensive distribution network ensures steady sales and revenues and also benefits its market awareness, visibility and reputation and hence further consolidates its brand. It has also worked out a plan to extend its products to the international markets, making a solid basis for its internationalization.

 

Outlook 

Shenzhen Neptunus Interlong Bio-Technique Co. LTD has accumulated considerable experience and achieved a high level of visibility in the domestic market with the help of its tremendous capability of research and development, professional marketing skill, stringent quality control and excellent management. In particular, it has secured dominant market coverage in China. It will continue to upgrade its capability of research and development and expand its production facilities to extend its product lines utilizing advanced techniques. Besides, it will also further broaden its business coverage to the international markets to become a giant in pursuit of the well-being of mankind.


All rights reserved. Shenzhen Neptunus Interlong Bio-Tech Co., Ltd. COPYRIGHT 2005-2006 粤ICP备11028550号-1